Online-Ressource | |
Verfasst von: | Hauswald, Henrik [VerfasserIn] |
Milker-Zabel, Stefanie [VerfasserIn] | |
Sterzing, Florian [VerfasserIn] | |
Schlegel, Wolfgang [VerfasserIn] | |
Debus, Jürgen [VerfasserIn] | |
Zabel-du Bois, Angelika [VerfasserIn] | |
Titel: | Repeated linac-based radiosurgery in high-grade cerebral arteriovenous-malformations (AVM) Spetzler-Martin grade III to IV previously treated with radiosurgery |
Verf.angabe: | Henrik Hauswald, Stefanie Milker-Zabel, Florian Sterzing, Wolfgang Schlegel, Juergen Debus, Angelika Zabel-du Bois |
E-Jahr: | 2011 |
Jahr: | [February 2011] |
Umfang: | 6 S. |
Fussnoten: | Gesehen am 23.09.2022 |
Titel Quelle: | Enthalten in: Radiotherapy and oncology |
Ort Quelle: | Amsterdam [u.a.] : Elsevier Science, 1983 |
Jahr Quelle: | 2011 |
Band/Heft Quelle: | 98(2011), 2 vom: Feb., Seite 217-222 |
ISSN Quelle: | 1879-0887 |
Abstract: | Background - Aim was to access outcome and toxicity of repeated linac-based radiosurgery in incompletely obliterated cerebral AVM. - Patients and methods - Between 1998 and 2008, 11 patients were treated with repeated radiosurgery. The median dose to the 80%-isodose was 15Gy (range, 12-18Gy). During initial radiosurgery the median dose was 18Gy (range, 9-22Gy). - Results - The median time interval between initial radiosurgery and re-treatment was 9years (range, 4-16years). The median follow-up was 26months (range, 2-115months). Treatment response was seen in 8 patients (89%). Complete (partial) obliteration was achieved in 5 (3) patients (56%, 33%, respectively).The median time to complete obliteration was 26months (range, 5-45months). Pre-existing neurological symptoms improved in 2 patients (18%), were stable in 7 patients (64%) and worsened in 2 patients (18%). Prevalence of intracranial hemorrhage was 9% (1/11). Post-re-treatment intracranial hemorrhage rate was 2.7% (1/38years at risk). During follow-up, no secondary malignancies or toxicity>grade III were observed. - Conclusion - Repeated linac-based radiosurgery in incompletely obliterated cerebral AVM is an effective treatment option with a high rate of treatment response and an acceptable risk for side effects. Marginal doses above 15Gy might further improve the rate of complete obliterations. |
DOI: | doi:10.1016/j.radonc.2011.01.002 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt. Volltext ; Verlag: https://doi.org/10.1016/j.radonc.2011.01.002 |
Volltext: https://www.sciencedirect.com/science/article/pii/S0167814011000168 | |
DOI: https://doi.org/10.1016/j.radonc.2011.01.002 | |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Arteriovenous malformation |
AVM | |
Incomplete obliteration | |
Radiosurgery | |
Radiotherapy | |
Reirradiation | |
K10plus-PPN: | 1817352148 |
Verknüpfungen: | → Zeitschrift |